Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Interactions between genistein and Wnt pathway in colon adenocarcinoma and early embryos

ABSTRACT: Interactions between genistein and Wnt pathway in colon adenocarcinoma and early embryos

PROVIDER: PRJNA1119549 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR29269769_1.fastq.gz	Fastqsanger.gz
	SRR29269769_2.fastq.gz	Fastqsanger.gz
	SRR29269770_1.fastq.gz	Fastqsanger.gz
	SRR29269770_2.fastq.gz	Fastqsanger.gz
	SRR29269771_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 48

Similar Datasets

Interactions between genistein and Wnt pathway in colon adenocarcinoma and early embryos

Project description:The Wnt signaling pathway is one of the most ancient and pivotal signaling cascades, governing diverse processes in development and cancer regulation. Within the realm of cancer treatment, genistein emerges as a promising candidate due to its multifaceted modulation of various signaling pathways, including the Wnt pathway. Despite promising preclinical studies, the precise mechanisms underlying genistein's therapeutic effects via Wnt modulation remain elusive. In this study, we unveil novel insights into the therapeutic mechanisms of genistein by elucidating its inhibitory effects on Wnt signaling through macropinocytosis. Additionally, we demonstrate its capability to curtail cell growth, proliferation, and lysosomal activity in the SW480 colon adenocarcinoma cell model. Furthermore, our investigation extends to the embryonic context, where genistein influences gene regulatory networks governed by endogenous Wnt pathways. Our findings shed light on the intricate interplay between genistein, Wnt signaling, membrane trafficking, and gene regulation, paving the way for further exploration of genistein's therapeutic potential in cancer treatment strategies.

2024-06-03 | GSE268980 | GEO

Genistein in Treatment of Metastatic Colorectal Cancer

Project description:Colorectal neoplasms are the third most common malignancies in the United States. Patients with metastatic (stage IV) colorectal cancer have a median life expectancy of 2 years. The response rates to chemotherapy range from 35-40%. Epidemiologic evidence suggests that soy compounds may reduce the incidence of colorectal cancers. Laboratory analyses demonstrate that genistein, a soy-derived compound, may inhibit Wnt signaling, a pathway activated in majority of colorectal cancers. Laboratory observations also demonstrate that genistein may augment growth inhibition when combined with chemotherapeutic agents of 5-Fluorouracil and platinum compounds. Based on pre-clinical data the investigators hypothesize that combining genistein with the standard of care chemotherapeutic regimens will reduce chemotherapy resistance and improve response rates in patients. The aim of the study is to add genistein to the regimens of FOLFOX or FOLFOX-Avastin in patients with newly diagnosed stage IV colon or rectal neoplasms.

| 2154917 | ecrin-mdr-crc

Expression data of colon adenocarcinoma and normal colon

Project description:Expression data of colon adenocarcinoma and normal colon

| PRJNA474422 | ENA

Expression data of colon adenocarcinoma and normal colon

Project description:To identiy the differentially expressed gene between in colon adenocarcinoma and normal colon, we performed microarray to quantify the gene expressions.

2018-12-31 | GSE115261 | GEO

Epigenetic analysis of normal colon epithelium and colon adenocarcinoma

Project description:Genome-wide DNA methylation profiles were obtained from colon adenocarcinoma samples (22), corresponding normal colon tissue (22) and cancer-unrelated normal colon tissue using Illumina HumanMethylation450 BeadChips. Approximately 485000 CpG sites were measured in every sample.

2012-12-06 | GSE42752 | GEO

Transcriptome response to genistein in zebrafish embryos

2012-11-01 | GSE34616 | GEO

Transcriptome response to genistein in zebrafish embryos

Project description:To test wether endocrine disruption is detectable in zebrafish at the transcriptome level, we exposed newly fertilized zebrafish embryos to low doses of genistein (EC10 and EC20) for 48 hours. Newly fertilized embryos (<2hpf) were exposed to 2.2 mg/l (EC10) and 2.4 mg/l (EC20) genistein for 48 hours. Since aceton was used as a solvent for genistein, an acetone solvent control in addition to the water (ISO) control was included in the study. Overall, four replicates were performed per condition, each consisting of 24 pooled embryos.

2012-11-01 | E-GEOD-34616 | biostudies-arrayexpress

The effect of SubAB treatment on Wnt-High and Wnt-Low sorted human colon cancer stem cells

Project description:The effect of ER-stress and subsequent activation of the unfolded protein response was investigated in colon cancer stem cells and more differentiated colon cancer cells Human colon cancer derived spheroid cultures with a TCF/LEF driven GFP reporter for Wnt signaling activity were treated for 24 hours with SubAB or protease-dead SubABco (1Âµg/ml) Treated spheroid cultures were sorted into colon-cancer stem cell fraction (highest 10% Wnt-GFP) and differentiated colon cancer fraction (10% Lowest(Wnt Low) for micro array

2015-02-12 | E-GEOD-65879 | biostudies-arrayexpress

Epigenetic analysis of normal colon epithelium and colon adenocarcinoma

2012-12-06 | E-GEOD-42752 | biostudies-arrayexpress

Genotyping of paired samples of normal colon and colon adenocarcinoma to estimate copy-number alterations

Project description:22 pairs of normal colon\colon adenocarcinoma samples were genotyped using Illumina HumanOmni1-Quad BeadChip to estimate copy number alterations Genomic DNA of 22 colon adenocarcinoma samples and 22 corresponding normal colon samples were genotyped using Illumina HumanOmni1-Quad BeadChip to estimate copy number alterations.

2013-02-01 | E-GEOD-43933 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data